The COVID-19 pandemic has created excruciating burden for the healthcare sector. Dhiti Omics Technologies is happy to announce the launch of RT-PCR based COVID19 testing from its’ state of the art NABL accredited and ICMR approved PCR labs.
Our high-throughput COVID-19 testing facility is equipped to handle regular and surge capacity testing. We shall test at scale to assist hospitals, clinics, and nursing homes; high impact communities; educational institutions; and individuals.
We are ICMR approved and NABL accredited to offer a qualitative 3 gene RT-PCR assay for testing of SARS-CoV-2. The performance of this test has been established using nasopharyngeal swab and oropharyngeal swab samples. Bronchoalveolar lavage and other swabs (mid-turbinate and anterior nasal)/washes/aspirates are also considered acceptable specimen types, although the performance has not been established. The testing is offered with a turnaround time [TAT] of 24-48 hours.
On site testing with Rapid Antigen and Rapid Antibody using ICMR, CE and WHO approved lateral flow assays are also available.